[Risk-benefit analysis of a hCG-500 kcal reducing diet (cura romana) in females]
- PMID: 3609673
- DOI: 10.1055/s-2008-1035826
[Risk-benefit analysis of a hCG-500 kcal reducing diet (cura romana) in females]
Abstract
The British physician A.T.W. Simeons described in 1954 a new method for dieting. He combined a reduction diet (500 kcal per day) with daily injections of the pregnancy hormone human chorionic gonadotropin (hCG) (125 IU i.m.). According to Simeons the patient should not lose more weight during a 4-to-6 weeks' diet than without hCG, but the injections should facilitate to maintain the diet and to lose body weight at specific parts of the body (e.g. hip, belly, thigh). After the first publication various studies conducted with male and female patients analysed the efficacy of the "Cura romana". 10 of these studies showed positive and another 10 studies negative results with regard to hCG-related weight reduction. Two of these studies with positive results were double-blind studies (hCG vs. placebo). Most of them were reports on therapeutical experiences and were not controlled studies. According to these reports the body proportions normalized and the feeling of hunger was tolerable. Four out of 10 studies with negative results were controlled studies (hCG vs. control without hCG), whereas 6 were double-blind studies. These studies showed a significant weight reduction during dieting, but no differences between treatment groups in respect of body weight, body proportions and feeling of hunger. One of them is the only German study conducted by Rabe et al. in 1981 in which 82 randomised premenopausal volunteers had been dieting either with hCG or without hCG injections. In recent publications describing mostly well-documented double-blind studies authors largely reject hCG administration in dieting. Supporters of the hCG diet must prove the efficacy of this method in controlled studies according to the German Drug Law. Until then the opinion of the German steroid toxicology panel is still valid, that hCG is ineffective in dieting and should not be used (Bolt 1982 a, 1982 b).
Similar articles
-
Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method.West J Med. 1977 Dec;127(6):461-3. West J Med. 1977. PMID: 595585 Free PMC article.
-
By the way, doctor. I've been trying to lose weight for a long time and nothing seems to work. What do you know about the HCG diet?Harv Womens Health Watch. 2010 May;17(9):8. Harv Womens Health Watch. 2010. PMID: 20593560 No abstract available.
-
Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.Br J Nutr. 2008 May;99(5):1157-67. doi: 10.1017/S0007114507853335. Epub 2007 Nov 1. Br J Nutr. 2008. PMID: 17977472 Clinical Trial.
-
Evidence for, and Associated Risks with, the Human Chorionic Gonadotropin Supplemented Diet.J Diet Suppl. 2016 Nov;13(6):694-9. doi: 10.3109/19390211.2016.1156208. Epub 2016 Mar 24. J Diet Suppl. 2016. PMID: 27010890 Review.
-
Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment.Aesthetic Plast Surg. 1987;11(1):131-56. doi: 10.1007/BF01575502. Aesthetic Plast Surg. 1987. PMID: 3314409 Review.
Cited by
-
Effect of weight reduction on cardiovascular risk factors and CD34-positive cells in circulation.Int J Med Sci. 2011;8(6):445-52. doi: 10.7150/ijms.8.445. Epub 2011 Aug 1. Int J Med Sci. 2011. PMID: 21850193 Free PMC article. Clinical Trial.
-
The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis.Br J Clin Pharmacol. 1995 Sep;40(3):237-43. doi: 10.1111/j.1365-2125.1995.tb05779.x. Br J Clin Pharmacol. 1995. PMID: 8527285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical